Interact to see
Advertisement
Advertisement
NEMRX vs VEMAX
NEMRX vs VEMAX Comparison
Open Charts NEMRX vs VEMAX
Neuberger Berman Emerg Mkts Eq R3
Price$25.94
Change+$0.04 (+0.15%)
VolumeN/A
Net Assets228.6M
Vanguard Emerging Mkts Stock Idx Adm
Price$45.65
Change+$0.18 (+0.40%)
VolumeN/A
Net Assets138.25B
NEMRX vs VEMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
NEMRX vs. VEMAX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEMRX is a Buy and VEMAX is a Buy.
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 138B vs. NEMRX (229M). VEMAX pays higher dividends than NEMRX: VEMAX (2.78) vs NEMRX (0.00). NEMRX was incepted earlier than VEMAX: NEMRX (15 years) vs VEMAX (19 years). NEMRX (2.25) is less costly to investors than VEMAX (0.13). NEMRX is a more actively managed with annual turnover of: 111.00 vs. VEMAX (8.00). NEMRX has a lower initial minimum investment than VEMAX: NEMRX (0) vs VEMAX (3000). NEMRX annual gain was more profitable for investors over the last year : 23.45 vs. VEMAX (14.21). VEMAX return over 5 years is better than : 36.62 vs. NEMRX (28.76).
| NEMRX | VEMAX | NEMRX / VEMAX | |
| Total Expense Ratio | 1.95 | 0.13 | 1,500% |
| Annual Report Gross Expense Ratio | 2.25 | 0.13 | 1,731% |
| Fund Existence | 15 years | 19 years | - |
| Gain YTD | 33.094 | 24.344 | 136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 229M | 138B | 0% |
| Annual Yield % from dividends | 0.00 | 2.78 | - |
| Returns for 1 year | 23.45 | 14.21 | 165% |
| Returns for 3 years | 63.67 | 56.90 | 112% |
| Returns for 5 years | 28.76 | 36.62 | 79% |
| Returns for 10 years | 81.58 | 79.36 | 103% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement